Jigisha R. Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jigisha R. Patel has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alec Z. Jacinto
Roseman University of Health Sciences, School of Pharmacy, Henderson, NV 89014, USA
1 shared publication - Christopher H. So
Roseman University of Health Sciences School of Pharmacy, Henderson, USA
1 shared publication - Jane C. Ammon
Roseman University of Health Sciences, School of Pharmacy, Henderson, NV 89014, USA
1 shared publication - Li Feng Feng
Roseman University of Health Sciences, School of Pharmacy, Henderson, NV 89014, USA
1 shared publication - Lysa Le
Roseman University of Health Sciences, School of Pharmacy, Henderson, NV 89014, USA
1 shared publication - Michael Gi
Roseman University of Health Sciences, School of Pharmacy, Henderson, NV 89014, USA
1 shared publication
Latest Publications
- 1 August 2021
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 99 (4) , 508-518
G protein coupled receptor kinase 5 modifies the nucleolar stress response activated by actinomycin D
G protein coupled receptor kinase 5 (GRK5) is localized within the nucleus and moderates functions such as DNA transcription, in addition to its localization at the plasma membrane. In this report, we show that GRK5 modifies the nucleolar stress response activated by the DNA polymerase inhibitor, actinomycin D (ActD). We show an increased sensitivity to the apoptotic effects of ActD on cervical HeLa cells and the breast cancer cell line MDA MB 231 with reduced protein expression of GRK5. We also tested two types of breast cancer cells (MDA MB 231 and MCF7 cells) and found that the rate of response to ActD varied between them because they have innate differences in the protein expression of GRK5. We also found that GRK5 phosphorylates nucleophosmin (NPM1) at T199 before and during the early stages of ActD treatment. Phosphorylation at T199 increases the ability of NPM1 to interact with p14ARF in vitro, which may affect the protein expression levels of p14ARF. We found that the expression levels of p14ARF were lower in the cells transfected with the control shRNA, but higher in cells transfected with GRK5 shRNA. Collectively, this suggests that GRK5 modifies the nucleolar stress response associated with ActD.
- 1 August 2021
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 99 (4) , 508-518
G protein coupled receptor kinase 5 modifies the nucleolar stress response activated by actinomycin D
G protein coupled receptor kinase 5 (GRK5) is localized within the nucleus and moderates functions such as DNA transcription, in addition to its localization at the plasma membrane. In this report, we show that GRK5 modifies the nucleolar stress response activated by the DNA polymerase inhibitor, actinomycin D (ActD). We show an increased sensitivity to the apoptotic effects of ActD on cervical HeLa cells and the breast cancer cell line MDA MB 231 with reduced protein expression of GRK5. We also tested two types of breast cancer cells (MDA MB 231 and MCF7 cells) and found that the rate of response to ActD varied between them because they have innate differences in the protein expression of GRK5. We also found that GRK5 phosphorylates nucleophosmin (NPM1) at T199 before and during the early stages of ActD treatment. Phosphorylation at T199 increases the ability of NPM1 to interact with p14ARF in vitro, which may affect the protein expression levels of p14ARF. We found that the expression levels of p14ARF were lower in the cells transfected with the control shRNA, but higher in cells transfected with GRK5 shRNA. Collectively, this suggests that GRK5 modifies the nucleolar stress response associated with ActD.